Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic ...

Welcome, ladies and gentlemen, to the fourth quarter and fiscal year 2024 earnings conference call for Tactile Medical. (Operator Instructions) Please note that this conference call is being recorded ...

A five-factor risk model effectively predicted 2-year lymphedema-free survival among a cohort of patients with breast cancer, ...

Q4 2024 Earnings Call Transcript February 18, 2025 Tactile Systems Technology, Inc. beats earnings expectations. Reported EPS ...

Tactile Systems projects 2025 full-year revenue between $316 million and $322 million, representing an 8%-10% year-over-year growth. Guidance assumes 8%-10% growth in the Lymphedema product line and 6 ...

Reports Q4 revenue $85.6M, consensus $85.39M. “Our fourth quarter results capped off a dynamic year for Tactile, during which we launched our ...

Healthpoint to offer advanced therapies for lipedema and lymphedema via a dedicated multidisciplinary team, ensuring ...